
APVO
Healthcare · Biotechnology · $2.9M market cap
$0.5941-0.07 (-10.0%)Nov 13, 4:27 PM EST
Next report
Time not confirmed
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · +40.6% over 90 days · 30-day revisions 0 up, 1 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 19, 2026 · upcoming | Time not confirmed | -3.72 | -40.11 | -978.2% |
| Aug 14, 2026 | Before the open | -6.02 | -5.31 | +11.8% |
| May 13, 2026 | After the close | -5.60 | -6.41 | -14.5% |
| Mar 26, 2026 | Time not confirmed | -8.09 | -5.91 | +26.9% |
| Nov 6, 2025 | After the close | -37.62 | -40.14 | -6.7% |
| Aug 11, 2025 | Before the open | -1497.60 | -151.20 | +89.9% |
| May 15, 2025 | After the close | -4.21 | -4.39 | -4.3% |
| Feb 14, 2025 | Before the open | -2790.00 | -3218.40 | -15.4% |
| Nov 7, 2024 | Before the open | -7592.40 | -6393.60 | +15.8% |
| Aug 8, 2024 | Before the open | -25707.61 | -22244.40 | +13.5% |
| May 8, 2024 | Before the open | -171095.43 | -132534.03 | +22.5% |
| Mar 5, 2024 | Before the open | -18.04 | -6.16 | +65.9% |
| Nov 14, 2023 | Before the open |
Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against…
| -439559.56 |
| -293039.71 |
| +33.3% |
| Aug 10, 2023 | Before the open | -656408.94 | -720877.68 | -9.8% |
| May 11, 2023 | Before the open | -638826.56 | -652892.47 | -2.2% |
| Mar 30, 2023 | Before the open | -1.53 | -0.95 | +37.9% |
| Nov 10, 2022 | Before the open | -890840.71 | -899045.82 | -0.9% |
| Aug 11, 2022 | Before the open | -779485.62 | -1000000.00 | -28.3% |
| May 12, 2022 | Before the open | -673991.33 | -931866.27 | -38.3% |
| Mar 24, 2022 | Before the open | -1.29 | -1.27 | +1.6% |
| Nov 12, 2021 | Before the open | -679852.12 | -838093.56 | -23.3% |
| Aug 12, 2021 | After the close | -1000000.00 | -1000000.00 | 0.0% |
| May 11, 2021 | Before the open | -990474.21 | -1000000.00 | -1.0% |
| Mar 31, 2021 | Before the open | -1.22 | -1.92 | -57.4% |
| Nov 10, 2020 | After the close | -1000000.00 | -1000000.00 | 0.0% |
| Aug 14, 2020 | After the close | -1000000.00 | -1000000.00 | 0.0% |
| May 13, 2020 | Before the open | -2.35 | -2.84 | -20.9% |
| Mar 25, 2020 | After the close | -1000000.00 | -984614.40 | +1.5% |
| Nov 7, 2019 | Before the open | -1000000.00 | -1000000.00 | 0.0% |
| Aug 9, 2019 | Before the open | -1000000.00 | -1000000.00 | 0.0% |
| May 9, 2019 | Before the open | -1000000.00 | -1000000.00 | 0.0% |
| Mar 18, 2019 | Before the open | -7.47 | -8.68 | -16.2% |
| Nov 14, 2018 | After the close | -1000000.00 | -1000000.00 | 0.0% |
| Aug 9, 2018 | Before the open | -1000000.00 | -1000000.00 | 0.0% |
| May 10, 2018 | Before the open | -1000000.00 | -1000000.00 | 0.0% |
| Mar 13, 2018 | Before the open | -4.48 | -6.44 | -43.8% |